nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Tonsillitis—Mitoxantrone—sarcoma	0.0514	0.0514	CcSEcCtD
Cefprozil—Nephropathy toxic—Mitoxantrone—sarcoma	0.0226	0.0226	CcSEcCtD
Cefprozil—Nephropathy toxic—Etoposide—sarcoma	0.0188	0.0188	CcSEcCtD
Cefprozil—Prothrombin level increased—Epirubicin—sarcoma	0.0148	0.0148	CcSEcCtD
Cefprozil—Colitis—Thiotepa—sarcoma	0.0144	0.0144	CcSEcCtD
Cefprozil—Blood urea increased—Thiotepa—sarcoma	0.0142	0.0142	CcSEcCtD
Cefprozil—Aplastic anaemia—Dactinomycin—sarcoma	0.014	0.014	CcSEcCtD
Cefprozil—Prothrombin level increased—Doxorubicin—sarcoma	0.0137	0.0137	CcSEcCtD
Cefprozil—Blood urea increased—Mitoxantrone—sarcoma	0.0123	0.0123	CcSEcCtD
Cefprozil—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.0118	0.0118	CcSEcCtD
Cefprozil—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.0109	0.0109	CcSEcCtD
Cefprozil—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.0104	0.0104	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00975	0.00975	CcSEcCtD
Cefprozil—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.00964	0.00964	CcSEcCtD
Cefprozil—Pancytopenia—Thiotepa—sarcoma	0.00896	0.00896	CcSEcCtD
Cefprozil—Pancytopenia—Dactinomycin—sarcoma	0.00889	0.00889	CcSEcCtD
Cefprozil—Neutropenia—Dactinomycin—sarcoma	0.00875	0.00875	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00827	0.00827	CcSEcCtD
Cefprozil—Pancytopenia—Vincristine—sarcoma	0.00794	0.00794	CcSEcCtD
Cefprozil—Agranulocytosis—Thiotepa—sarcoma	0.00785	0.00785	CcSEcCtD
Cefprozil—Neutropenia—Vincristine—sarcoma	0.00782	0.00782	CcSEcCtD
Cefprozil—Agranulocytosis—Dactinomycin—sarcoma	0.00779	0.00779	CcSEcCtD
Cefprozil—Pancytopenia—Mitoxantrone—sarcoma	0.00773	0.00773	CcSEcCtD
Cefprozil—Neutropenia—Mitoxantrone—sarcoma	0.00762	0.00762	CcSEcCtD
Cefprozil—Haemoglobin—Thiotepa—sarcoma	0.00759	0.00759	CcSEcCtD
Cefprozil—Haemorrhage—Thiotepa—sarcoma	0.00755	0.00755	CcSEcCtD
Cefprozil—Pharyngitis—Dactinomycin—sarcoma	0.00744	0.00744	CcSEcCtD
Cefprozil—Drowsiness—Mitoxantrone—sarcoma	0.00726	0.00726	CcSEcCtD
Cefprozil—Erythema multiforme—Dactinomycin—sarcoma	0.00708	0.00708	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00706	0.00706	CcSEcCtD
Cefprozil—Jaundice cholestatic—Epirubicin—sarcoma	0.00689	0.00689	CcSEcCtD
Cefprozil—Agranulocytosis—Mitoxantrone—sarcoma	0.00678	0.00678	CcSEcCtD
Cefprozil—Erythema—Thiotepa—sarcoma	0.00657	0.00657	CcSEcCtD
Cefprozil—Haemoglobin—Mitoxantrone—sarcoma	0.00655	0.00655	CcSEcCtD
Cefprozil—Erythema—Dactinomycin—sarcoma	0.00652	0.00652	CcSEcCtD
Cefprozil—Haemorrhage—Mitoxantrone—sarcoma	0.00652	0.00652	CcSEcCtD
Cefprozil—Pharyngitis—Mitoxantrone—sarcoma	0.00647	0.00647	CcSEcCtD
Cefprozil—Tension—Thiotepa—sarcoma	0.00645	0.00645	CcSEcCtD
Cefprozil—Pancytopenia—Etoposide—sarcoma	0.00643	0.00643	CcSEcCtD
Cefprozil—Nervousness—Thiotepa—sarcoma	0.00638	0.00638	CcSEcCtD
Cefprozil—Jaundice cholestatic—Doxorubicin—sarcoma	0.00637	0.00637	CcSEcCtD
Cefprozil—Neutropenia—Etoposide—sarcoma	0.00634	0.00634	CcSEcCtD
Cefprozil—Vaginal inflammation—Epirubicin—sarcoma	0.00605	0.00605	CcSEcCtD
Cefprozil—Agitation—Thiotepa—sarcoma	0.00604	0.00604	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00599	0.00599	CcSEcCtD
Cefprozil—Colitis—Epirubicin—sarcoma	0.00581	0.00581	CcSEcCtD
Cefprozil—Blood urea increased—Epirubicin—sarcoma	0.00571	0.00571	CcSEcCtD
Cefprozil—Vaginal infection—Epirubicin—sarcoma	0.00571	0.00571	CcSEcCtD
Cefprozil—Convulsion—Thiotepa—sarcoma	0.00569	0.00569	CcSEcCtD
Cefprozil—Aplastic anaemia—Epirubicin—sarcoma	0.00568	0.00568	CcSEcCtD
Cefprozil—Erythema—Mitoxantrone—sarcoma	0.00568	0.00568	CcSEcCtD
Cefprozil—Agranulocytosis—Etoposide—sarcoma	0.00564	0.00564	CcSEcCtD
Cefprozil—Vaginal inflammation—Doxorubicin—sarcoma	0.0056	0.0056	CcSEcCtD
Cefprozil—Confusional state—Thiotepa—sarcoma	0.00541	0.00541	CcSEcCtD
Cefprozil—Colitis—Doxorubicin—sarcoma	0.00538	0.00538	CcSEcCtD
Cefprozil—Agitation—Vincristine—sarcoma	0.00536	0.00536	CcSEcCtD
Cefprozil—Vaginal infection—Doxorubicin—sarcoma	0.00529	0.00529	CcSEcCtD
Cefprozil—Blood urea increased—Doxorubicin—sarcoma	0.00529	0.00529	CcSEcCtD
Cefprozil—Aplastic anaemia—Doxorubicin—sarcoma	0.00526	0.00526	CcSEcCtD
Cefprozil—Thrombocytopenia—Thiotepa—sarcoma	0.00525	0.00525	CcSEcCtD
Cefprozil—Thrombocytopenia—Dactinomycin—sarcoma	0.00521	0.00521	CcSEcCtD
Cefprozil—Erythema multiforme—Etoposide—sarcoma	0.00513	0.00513	CcSEcCtD
Cefprozil—Convulsion—Vincristine—sarcoma	0.00505	0.00505	CcSEcCtD
Cefprozil—Convulsion—Mitoxantrone—sarcoma	0.00492	0.00492	CcSEcCtD
Cefprozil—Somnolence—Thiotepa—sarcoma	0.00477	0.00477	CcSEcCtD
Cefprozil—Anaphylactic shock—Vincristine—sarcoma	0.00476	0.00476	CcSEcCtD
Cefprozil—Confusional state—Mitoxantrone—sarcoma	0.00467	0.00467	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Epirubicin—sarcoma	0.00466	0.00466	CcSEcCtD
Cefprozil—Thrombocytopenia—Vincristine—sarcoma	0.00466	0.00466	CcSEcCtD
Cefprozil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00463	0.00463	CcSEcCtD
Cefprozil—Pain—Thiotepa—sarcoma	0.00459	0.00459	CcSEcCtD
Cefprozil—Pain—Dactinomycin—sarcoma	0.00455	0.00455	CcSEcCtD
Cefprozil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00453	0.00453	CcSEcCtD
Cefprozil—Feeling abnormal—Thiotepa—sarcoma	0.00442	0.00442	CcSEcCtD
Cefprozil—Feeling abnormal—Dactinomycin—sarcoma	0.00439	0.00439	CcSEcCtD
Cefprozil—Gastrointestinal pain—Thiotepa—sarcoma	0.00439	0.00439	CcSEcCtD
Cefprozil—Gastrointestinal pain—Dactinomycin—sarcoma	0.00435	0.00435	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00431	0.00431	CcSEcCtD
Cefprozil—Insomnia—Vincristine—sarcoma	0.0043	0.0043	CcSEcCtD
Cefprozil—Urticaria—Thiotepa—sarcoma	0.00426	0.00426	CcSEcCtD
Cefprozil—Abdominal pain—Thiotepa—sarcoma	0.00424	0.00424	CcSEcCtD
Cefprozil—Body temperature increased—Thiotepa—sarcoma	0.00424	0.00424	CcSEcCtD
Cefprozil—Abdominal pain—Dactinomycin—sarcoma	0.00421	0.00421	CcSEcCtD
Cefprozil—Body temperature increased—Dactinomycin—sarcoma	0.00421	0.00421	CcSEcCtD
Cefprozil—Somnolence—Mitoxantrone—sarcoma	0.00412	0.00412	CcSEcCtD
Cefprozil—Convulsion—Etoposide—sarcoma	0.00409	0.00409	CcSEcCtD
Cefprozil—Pain—Vincristine—sarcoma	0.00407	0.00407	CcSEcCtD
Cefprozil—Pain—Mitoxantrone—sarcoma	0.00396	0.00396	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00396	0.00396	CcSEcCtD
Cefprozil—Hypersensitivity—Thiotepa—sarcoma	0.00395	0.00395	CcSEcCtD
Cefprozil—Hypersensitivity—Dactinomycin—sarcoma	0.00392	0.00392	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vincristine—sarcoma	0.00389	0.00389	CcSEcCtD
Cefprozil—Confusional state—Etoposide—sarcoma	0.00388	0.00388	CcSEcCtD
Cefprozil—Anaphylactic shock—Etoposide—sarcoma	0.00385	0.00385	CcSEcCtD
Cefprozil—Feeling abnormal—Mitoxantrone—sarcoma	0.00382	0.00382	CcSEcCtD
Cefprozil—Pruritus—Thiotepa—sarcoma	0.00379	0.00379	CcSEcCtD
Cefprozil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00379	0.00379	CcSEcCtD
Cefprozil—Thrombocytopenia—Etoposide—sarcoma	0.00377	0.00377	CcSEcCtD
Cefprozil—Eosinophilia—Epirubicin—sarcoma	0.00376	0.00376	CcSEcCtD
Cefprozil—Abdominal pain—Vincristine—sarcoma	0.00376	0.00376	CcSEcCtD
Cefprozil—Body temperature increased—Vincristine—sarcoma	0.00376	0.00376	CcSEcCtD
Cefprozil—Urticaria—Mitoxantrone—sarcoma	0.00368	0.00368	CcSEcCtD
Cefprozil—Diarrhoea—Thiotepa—sarcoma	0.00367	0.00367	CcSEcCtD
Cefprozil—Body temperature increased—Mitoxantrone—sarcoma	0.00366	0.00366	CcSEcCtD
Cefprozil—Abdominal pain—Mitoxantrone—sarcoma	0.00366	0.00366	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Cefprozil—Diarrhoea—Dactinomycin—sarcoma	0.00364	0.00364	CcSEcCtD
Cefprozil—Pancytopenia—Epirubicin—sarcoma	0.00361	0.00361	CcSEcCtD
Cefprozil—Neutropenia—Epirubicin—sarcoma	0.00355	0.00355	CcSEcCtD
Cefprozil—Dizziness—Thiotepa—sarcoma	0.00355	0.00355	CcSEcCtD
Cefprozil—Hypersensitivity—Vincristine—sarcoma	0.0035	0.0035	CcSEcCtD
Cefprozil—Eosinophilia—Doxorubicin—sarcoma	0.00348	0.00348	CcSEcCtD
Cefprozil—Somnolence—Etoposide—sarcoma	0.00343	0.00343	CcSEcCtD
Cefprozil—Hypersensitivity—Mitoxantrone—sarcoma	0.00341	0.00341	CcSEcCtD
Cefprozil—Vomiting—Thiotepa—sarcoma	0.00341	0.00341	CcSEcCtD
Cefprozil—Drowsiness—Epirubicin—sarcoma	0.00339	0.00339	CcSEcCtD
Cefprozil—Vomiting—Dactinomycin—sarcoma	0.00338	0.00338	CcSEcCtD
Cefprozil—Rash—Thiotepa—sarcoma	0.00338	0.00338	CcSEcCtD
Cefprozil—Dermatitis—Thiotepa—sarcoma	0.00338	0.00338	CcSEcCtD
Cefprozil—Headache—Thiotepa—sarcoma	0.00336	0.00336	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00336	0.00336	CcSEcCtD
Cefprozil—Rash—Dactinomycin—sarcoma	0.00336	0.00336	CcSEcCtD
Cefprozil—Pancytopenia—Doxorubicin—sarcoma	0.00334	0.00334	CcSEcCtD
Cefprozil—Pain—Etoposide—sarcoma	0.00329	0.00329	CcSEcCtD
Cefprozil—Neutropenia—Doxorubicin—sarcoma	0.00329	0.00329	CcSEcCtD
Cefprozil—Diarrhoea—Vincristine—sarcoma	0.00325	0.00325	CcSEcCtD
Cefprozil—Nausea—Thiotepa—sarcoma	0.00319	0.00319	CcSEcCtD
Cefprozil—Feeling abnormal—Etoposide—sarcoma	0.00317	0.00317	CcSEcCtD
Cefprozil—Diarrhoea—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Cefprozil—Nausea—Dactinomycin—sarcoma	0.00316	0.00316	CcSEcCtD
Cefprozil—Agranulocytosis—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Cefprozil—Gastrointestinal pain—Etoposide—sarcoma	0.00315	0.00315	CcSEcCtD
Cefprozil—Dizziness—Vincristine—sarcoma	0.00315	0.00315	CcSEcCtD
Cefprozil—Drowsiness—Doxorubicin—sarcoma	0.00313	0.00313	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00311	0.00311	CcSEcCtD
Cefprozil—Urticaria—Etoposide—sarcoma	0.00306	0.00306	CcSEcCtD
Cefprozil—Haemoglobin—Epirubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Cefprozil—Body temperature increased—Etoposide—sarcoma	0.00305	0.00305	CcSEcCtD
Cefprozil—Abdominal pain—Etoposide—sarcoma	0.00305	0.00305	CcSEcCtD
Cefprozil—Haemorrhage—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Cefprozil—Vomiting—Vincristine—sarcoma	0.00302	0.00302	CcSEcCtD
Cefprozil—Pharyngitis—Epirubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Cefprozil—Rash—Vincristine—sarcoma	0.003	0.003	CcSEcCtD
Cefprozil—Dermatitis—Vincristine—sarcoma	0.003	0.003	CcSEcCtD
Cefprozil—Headache—Vincristine—sarcoma	0.00298	0.00298	CcSEcCtD
Cefprozil—Vomiting—Mitoxantrone—sarcoma	0.00294	0.00294	CcSEcCtD
Cefprozil—Agranulocytosis—Doxorubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Cefprozil—Rash—Mitoxantrone—sarcoma	0.00292	0.00292	CcSEcCtD
Cefprozil—Dermatitis—Mitoxantrone—sarcoma	0.00292	0.00292	CcSEcCtD
Cefprozil—Headache—Mitoxantrone—sarcoma	0.0029	0.0029	CcSEcCtD
Cefprozil—Erythema multiforme—Epirubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Cefprozil—Hypersensitivity—Etoposide—sarcoma	0.00284	0.00284	CcSEcCtD
Cefprozil—Haemoglobin—Doxorubicin—sarcoma	0.00283	0.00283	CcSEcCtD
Cefprozil—Nausea—Vincristine—sarcoma	0.00282	0.00282	CcSEcCtD
Cefprozil—Haemorrhage—Doxorubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Cefprozil—Pharyngitis—Doxorubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Cefprozil—Nausea—Mitoxantrone—sarcoma	0.00275	0.00275	CcSEcCtD
Cefprozil—Pruritus—Etoposide—sarcoma	0.00273	0.00273	CcSEcCtD
Cefprozil—Erythema multiforme—Doxorubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Cefprozil—Erythema—Epirubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Cefprozil—Diarrhoea—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Cefprozil—Tension—Epirubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Cefprozil—Nervousness—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Cefprozil—Dizziness—Etoposide—sarcoma	0.00255	0.00255	CcSEcCtD
Cefprozil—Vomiting—Etoposide—sarcoma	0.00245	0.00245	CcSEcCtD
Cefprozil—Erythema—Doxorubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Cefprozil—Agitation—Epirubicin—sarcoma	0.00243	0.00243	CcSEcCtD
Cefprozil—Rash—Etoposide—sarcoma	0.00243	0.00243	CcSEcCtD
Cefprozil—Dermatitis—Etoposide—sarcoma	0.00243	0.00243	CcSEcCtD
Cefprozil—Headache—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Cefprozil—Tension—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Cefprozil—Nervousness—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Cefprozil—Convulsion—Epirubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Cefprozil—Nausea—Etoposide—sarcoma	0.00229	0.00229	CcSEcCtD
Cefprozil—Agitation—Doxorubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Cefprozil—Confusional state—Epirubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Cefprozil—Anaphylactic shock—Epirubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Cefprozil—Convulsion—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Cefprozil—Thrombocytopenia—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Cefprozil—Confusional state—Doxorubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Cefprozil—Anaphylactic shock—Doxorubicin—sarcoma	0.002	0.002	CcSEcCtD
Cefprozil—Thrombocytopenia—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Cefprozil—Insomnia—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Cefprozil—Somnolence—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Cefprozil—Pain—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Cefprozil—Insomnia—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Cefprozil—Feeling abnormal—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Cefprozil—Somnolence—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Cefprozil—Gastrointestinal pain—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Cefprozil—Urticaria—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefprozil—Pain—Doxorubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefprozil—Body temperature increased—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefprozil—Abdominal pain—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefprozil—Feeling abnormal—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Cefprozil—Gastrointestinal pain—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Cefprozil—Hypersensitivity—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Cefprozil—Urticaria—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Cefprozil—Body temperature increased—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefprozil—Abdominal pain—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefprozil—Pruritus—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Cefprozil—Diarrhoea—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Cefprozil—Hypersensitivity—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Cefprozil—Dizziness—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Cefprozil—Pruritus—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Cefprozil—Vomiting—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Cefprozil—Diarrhoea—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Cefprozil—Rash—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Cefprozil—Dermatitis—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Cefprozil—Headache—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefprozil—Dizziness—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Cefprozil—Nausea—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Cefprozil—Vomiting—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Cefprozil—Rash—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefprozil—Dermatitis—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefprozil—Headache—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefprozil—Nausea—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
